Ultrasound AI solution for obstructive sleep apnea diagnosis and assessment using airway imaging. The system utilizes artificial intelligence to enhance detection accuracy and streamline OSA evaluation workflows.
Manufactured by
AmCad BioMed Corporation Co. Ltd.
Taipei City, Taiwan
AmCad BioMed is the world's first company to receive FDA approval for its ultrasound computer-aided diagnosis (CAD) system. Combining AI and clinical expertise, AmCad has developed four FDA, CE, and TFDA-certified AI-assisted CAD software, including "AmCAD-UT" for thyroid ultrasound detection and "AmCAD-UO" for rapid OSA screening. Driven by innovation, AmCad's patented technologies have earned numerous accolades, empowering healthcare professionals with enhanced diagnostic quality and superior patient experiences. A pioneer in ultrasound AI, AmCad redefines diagnostic precision and patient care.
© 2026 Suplivia · Home · Browse Products